CABA - Cabaletta Bio, Inc.

QQQ $ 481.15 $ 6.24 (1.31 %)

DIA $ 409.09 $ 2.37 (0.58 %)

SPY $ 559.11 $ 5.30 (0.96 %)

TLT $ 97.90 $ 0.45 (0.46 %)

GLD $ 231.62 $ -0.38 (-0.16 %)

Previous Close

$ 4.97

Open

Bid

$ 4.96 x 200

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 3.47 - $ 26.35

Volume

1,573,961

Average Volume

Market Cap

242.78M

Beta (5Y Monthly)

$ 1.54

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-15-2024	03-31-2024	10-Q
3	03-21-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-16-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-11-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-17-2022	12-31-2021	10-K
12	11-01-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-03-2021	03-31-2021	10-Q
15	03-16-2021	12-31-2020	10-K
16	11-10-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-12-2020	03-31-2020	10-Q
19	03-30-2020	12-31-2019	10-K
20	12-05-2019	09-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Wells Fargo Maintains Overweight on Cabale...
08/12/2024 17:41:50

Wells Fargo analyst Derek Archila maintains Cabaletta Bio (NASDAQ:CABA) with a Overweight and lowers the price target from $...

Evercore ISI Group Maintains Outperform on...
08/12/2024 13:57:15

Evercore ISI Group analyst Gavin Clark-Gartner maintains Cabaletta Bio (NASDAQ:CABA) with a Outperform and lowers the price ...

HC Wainwright & Co. Maintains Buy on Cabal...
08/09/2024 21:00:21

HC Wainwright & Co. analyst Douglas Tsao maintains Cabaletta Bio (NASDAQ:CABA) with a Buy and lowers the price target fr...

Cabaletta Bio Q2 2024 GAAP EPS $(0.56) Mis...
08/08/2024 12:30:16

cell-therapy-mostly-used-for-blood-cancer-shows-efficacy-in-autoimmune-diseases-as-well-but-there-are-challenges

Cell Therapy Mostly Used For Blood Cancer ...
07/19/2024 17:45:01

CAR-T therapy, originally used for blood cancers, shows promising results in treating lupus, as evidenced by Janina Paech's...

why-kaival-brands-innovations-shares-are-trading-lower-by-47-here-are-other-stocks-moving-in-fridays-mid-day-session

Why Kaival Brands Innovations Shares Are T...
06/21/2024 18:04:00

Cantor Fitzgerald Reiterates Overweight on...
06/21/2024 15:19:04

Cantor Fitzgerald analyst Josh Schimmer reiterates Cabaletta Bio (NASDAQ:CABA) with a Overweight and maintains $50 price tar...

asana-clover-health-investments-hertz-global-and-other-big-stocks-moving-higher-on-friday

Asana, Clover Health Investments, Hertz Gl...
06/21/2024 14:45:13

why-quantum-shares-are-trading-lower-by-45-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Quantum Shares Are Trading Lower By 45...
06/18/2024 17:39:53

why-ammo-shares-are-trading-lower-by-over-19-here-are-other-stocks-moving-in-fridays-mid-day-session

Why AMMO Shares Are Trading Lower By Over ...
06/14/2024 18:13:08

HC Wainwright & Co. Reiterates Buy on Caba...
06/14/2024 15:09:29

HC Wainwright & Co. analyst Douglas Tsao reiterates Cabaletta Bio (NASDAQ:CABA) with a Buy and maintains $30 price target.

Cabaletta Bio Announces Initial Clinical D...
06/14/2024 07:25:17

– No CRS, ICANS, infections or serious adverse events observed in either of the first two patients through data cut-off of May ...

Cabaletta Bio 13G Filing Shows Jennison As...
06/06/2024 17:08:53

- SEC Filing

HC Wainwright & Co. Reiterates Buy on Caba...
05/24/2024 10:31:15

HC Wainwright & Co. analyst Douglas Tsao reiterates Cabaletta Bio (NASDAQ:CABA) with a Buy and maintains $30 price target.

HC Wainwright & Co. Reiterates Buy on Caba...
05/16/2024 11:54:44

HC Wainwright & Co. analyst Douglas Tsao reiterates Cabaletta Bio (NASDAQ:CABA) with a Buy and maintains $30 price target.

why-bolt-biotherapeutics-shares-are-trading-lower-by-around-34-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Bolt Biotherapeutics Shares Are Tradin...
05/15/2024 17:38:38

nextracker-posts-upbeat-earnings-joins-mondaycom-nu-holdings-and-other-big-stocks-moving-higher-on-wednesday

NEXTracker Posts Upbeat Earnings, Joins mo...
05/15/2024 14:21:59

Cabaletta Bio Expects That Its Cash, Cash ...
05/15/2024 11:12:43

Cabaletta Bio Q1 2024 GAAP EPS $(0.51) Mis...
05/15/2024 11:11:42

Cantor Fitzgerald Reiterates Overweight on...
04/05/2024 13:19:03

Cantor Fitzgerald analyst Joshua Schimmer reiterates Cabaletta Bio (NASDAQ:CABA) with a Overweight and maintains $50 price t...